Pseudophakia

01/01/1982 - "Argon laser treatment of a pupillary membrane in pseudophakia."
02/01/1977 - "Argon laser photocoagulation of the posterior segment in pseudophakia."
03/01/1997 - "This study evaluated the efficacy of argon laser trabeculoplasty (ALT) in patients with aphakia or pseudophakia. "
02/01/1977 - "The argon laser delivered through a slit lamp and contact lens optical system appears to be the preferred method for posterior segment photocoagulation in pseudophakia. "
02/01/1977 - "A series of in vitro, in vivo, and clinical studies was performed to explore the safety and efficacy of argon laser and xenon arc photocoagulation in pseudophakia. "

02/01/1977 - "A series of in vitro, in vivo, and clinical studies was performed to explore the safety and efficacy of argon laser and xenon arc photocoagulation in pseudophakia. "

01/01/2020 - "In stepwise multivariate analysis, significant parameters were silicone oil removal (R = 16.34%, odds ratio 13.45, P < 0.001), pseudophakia (R = 5.69%, odds ratio 3.65, P = 0.03), and younger age (R = 2.68%, odds ratio 0.96, P = 0.04). "
09/23/2014 - "Anterior migration of silicone oil in patients with pseudophakia is rare. "
09/01/2015 - "After phacoemulsification and silicone oil removal, AL measurements were repeated on same devices switched to standard pseudophakia modes. "
09/23/2014 - "We describe a 52-year-old patient with pseudophakia with silicone oil endotamponade presenting with visual loss and intraocular pressure of 60 mm Hg. Inferior YAG iridotomy was undertaken to repatriate silicone oil to the posterior segment. "
06/01/1995 - "Prognostic factors were preoperative aphakia or pseudophakia (P = .003), preoperative iris neovascularization (P = .006), reoperation (P = .001), the absence of a fluid/gas exchange (P = .03), corneal touch by silicone oil (P = .02), and the presence of aqueous cells (P = .009) or aqueous flare (P = .08). "

02/01/2013 - "Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'."
01/01/2012 - "Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia."
01/01/2003 - "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery. "
01/01/2003 - "Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery."

06/01/2007 - "Placement of the silicone tube in the posterior chamber sulcus is a safe and effective alternative technique for IOP control in patients with pseudophakia. "
01/01/1986 - "NMR imaging of eyes with intraocular silicone and pseudophakia are shown. "

10/01/2005 - "Change in best-corrected visual acuity after the intravitreal triamcinolone injection was statistically independent (P > .15) of age, sex, pseudophakia, and macula grid laser treatment before inclusion into the study. "
01/01/2019 - "The rate of IRT in vitrectomy is not significantly affected by surgical indication, preexisting PVD or pseudophakia, or use of triamcinolone or different viewing systems but is significantly higher in conventional vitrectomy. "
09/01/2003 - "Intravitreal triamcinolone injections were performed to treat refractory cystoid macular edema or diffuse macular edema associated with diabetic retinopathy, macular pucker, branch retinal vein occlusion, or pseudophakia. "
07/01/2005 - "Pseudophakia with impaired posterior capsule and the diagnosis of cystoid macular edema due to Irvine-Gass syndrome are two risk factors of sterile endophthalmitis following IVI triamcinolone. "

03/01/2001 - "Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia."
08/01/1996 - "A 77-year-old woman with bilateral pseudophakia and primary open-angle glaucoma was treated with ALT when her visual fields deteriorated despite topical timolol therapy. "
03/01/2001 - "Timolol and its preservative, benzalkonium chloride, cause disruption of the blood-aqueous barrier in early postoperative pseudophakia and increased incidence of angiographic CME. "
03/01/2001 - "To investigate the effects of timolol maleate with preservative and its preserved (PV) and nonpreserved vehicles (NPV) (benzalkonium chloride) on the blood-aqueous barrier and angiographic cystoid macular edema (CME) in early postoperative pseudophakia. "
09/01/2003 - "We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. "

02/01/2005 - "Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial."
09/01/2002 - "Cystoid macular edema in aphakia and pseudophakia after use of prostaglandin analogs."
07/01/2012 - "The aim of this prospective study was to examine the IOP lowering effect of selective laser trabeculoplasty (SLT) in patients on maximum tolerated medical therapy (MTMT), especially with regard to a potential influence of pseudophakia and topical prostaglandin analogues (PGA) on IOP reduction. "

01/01/2003 - "To report the development of cystoid macular edema following the use of topical latanoprost in an eye with glaucoma and pseudophakia. "
02/01/2005 - "Bimatoprost, latanoprost, and travoprost use may lead to disruption of the blood-aqueous barrier in patients with pseudophakia and aphakia."
09/01/2003 - "We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. "

10/01/2010 - "However, pseudophakia changes the physiology of the eye and immediate changes include release of inflammatory cytokines. "
09/01/2003 - "We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. "

09/29/2010 - "Concentric ring scanning laser ophthalmoscope artifacts and dysphotopsia in diffractive multifocal pseudophakia."
04/01/2014 - "Therefore we conclude that there was no clinically relevant influence of pseudophakia on the long-term effect of selective laser trabeculoplasty."
01/01/2011 - "To determine if pseudophakia affects selective laser trabeculoplasty (SLT) intraocular pressure (IOP) lowering effect. "
05/01/2007 - "To evaluate the effect of pseudophakia on the success of selective laser trabeculoplasty in lowering intraocular pressure (IOP). "
06/01/2003 - "A 30-diopter colored IOL showed an attenuation rate of up to 15% at a wavelength of 488 + 514 nm. Consideration of the wavelength and the output of a laser for a particular IOL is required when laser photocoagulation of the retina is performed in patients with pseudophakia."

11/01/2016 - "Age and pseudophakia also had significant effects on trabeculectomy failure based on criteria A and B, and the AL had a significant influence based on criterion A. "
11/01/2016 - "Younger age [hazard ratio (HR) for a 1-year increase 0.93, P < 0.005], preoperative pseudophakia (HR 3.88, P < 0.005), and shorter AL (HR for a 1-mm increase 0.72, P < 0.05) were found to be significant risk factors for trabeculectomy failure based on an IOP of ≤15 mmHg (criterion C). "
04/01/2014 - "Therefore we conclude that there was no clinically relevant influence of pseudophakia on the long-term effect of selective laser trabeculoplasty."
01/01/2011 - "To determine if pseudophakia affects selective laser trabeculoplasty (SLT) intraocular pressure (IOP) lowering effect. "
05/01/2007 - "To evaluate the effect of pseudophakia on the success of selective laser trabeculoplasty in lowering intraocular pressure (IOP). "

05/01/2018 - "We believe that wearing progressive additional lenses can be effective in improving the binocular vision in children with pseudophakia."
05/01/2018 - "Effects of Progressive Additional Lenses on Binocular Vision in Children with Pseudophakia."
11/01/2007 - "They provide a rationale for the increased clearly visible space depth phenomenon observed in patients with multiple pseudophakia and have calculated the reflection light energy loss caused by the presence of two artificial lenses. "
12/01/1994 - "The required time for clear vision tended to increase in diabetic cases, and also in pseudophakia corrected bifocal lenses, over 0.6 seconds. "
01/01/1991 - "Six hundred and eighty five eyes with pseudophakia after implantation of anterior chamber (162), posterior chamber (29) and pupillary lenses (494) were subjected to an analysis. "

09/01/1999 - "Clinical outcomes can now be improved in patients with myopic pseudophakia whose previous options (i.e., lens exchange or refractive surgery) were more traumatic or less predictable."
10/25/2023 - "Exclusion criteria included visually significant cataract, pseudophakia, prior refractive surgery, or age <18 years-old. "
11/01/2022 - "Contemporary statistical analysis of refractive error in adults, pseudophakia, and refractive surgery."
07/01/2014 - "Patients with documented history of cataract extraction (pseudophakia or aphakia), amblyopia, refractive surgery or other corneal/ocular surgery were excluded from the study. "

06/01/2003 - "A 30-diopter colored IOL showed an attenuation rate of up to 15% at a wavelength of 488 + 514 nm. Consideration of the wavelength and the output of a laser for a particular IOL is required when laser photocoagulation of the retina is performed in patients with pseudophakia."
02/01/1977 - "Argon laser photocoagulation of the posterior segment in pseudophakia."
02/01/1977 - "The argon laser delivered through a slit lamp and contact lens optical system appears to be the preferred method for posterior segment photocoagulation in pseudophakia. "
05/24/2021 - "Inclusion criteria: cDME for at least 2 years documented with OCT imaging; pseudophakia; previous treatments with laser photocoagulation and intravitreal injections of anti-VEGF and/or dexamethasone. "
02/01/1977 - "A series of in vitro, in vivo, and clinical studies was performed to explore the safety and efficacy of argon laser and xenon arc photocoagulation in pseudophakia. "